Liu Jie, Song Bao, Fan Tingyong, Huang Chengsuo, Xie Chao, Li Jing, Zhong Weixia, Li Sheng, Yu Jinming
Medical College, Shandong University, China.
Asian Pac J Cancer Prev. 2011;12(11):3055-61.
Non-Hodgkin's lymphomas (NHL) in China appear to have many characteristics different from those Western countries, but clinical studies to provide details have been rare so far.
This study retrospectively analyzed the characteristics of clinical and pathological data for the 1248 NHL patients in the Shandong region of China between 2002 and 2010.
From 2002 to 2010, the number of clinical cases of NHL increased year by year. Among the total, 64.7% were B-cell NHL, 30.3% were T-cell NHL, including: diffuse large B cell lymphoma (DLBCL) (40.9%), extranodal NK/T-cell lymphoma, nasal type (NK/T) (10.0%); peripheral T cell lymphoma, unspecified (PTL) (9.2%); follicular lymphoma (FL) (6.4%); extranodal marginal zone B cell lymphoma (MALT) (5.4%); precursor T lymphoblastic leukemia/lymphoma (T-LBL) (4.5%); and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (3.2%). The average age of onset was 47.7 ∓ 16.3 (18-85), and the male to female ratio was 1.57:1. Compared with Shanghai and Shanxi in China, the proportion of NK/T cell lymphoma in this region was higher. In comparison with other countries, the FL and CLL/SLL in this region were significantly lower, while the incidence of T-cell lymphoma was significantly higher than that in the United States and Europe.
The clinical and pathological distribution of NHL in Shandong region of China is consistent with that of Asian populations, but with significant difference from the Western countries. The NK/T cell lymphoma in this region was significantly higher.
中国的非霍奇金淋巴瘤(NHL)似乎具有许多与西方国家不同的特征,但迄今为止提供详细信息的临床研究很少。
本研究回顾性分析了2002年至2010年中国山东地区1248例NHL患者的临床和病理数据特征。
2002年至2010年,NHL临床病例数逐年增加。其中,64.7%为B细胞NHL,30.3%为T细胞NHL,包括:弥漫性大B细胞淋巴瘤(DLBCL)(40.9%)、鼻型结外NK/T细胞淋巴瘤(NK/T)(10.0%);外周T细胞淋巴瘤,非特指型(PTL)(9.2%);滤泡性淋巴瘤(FL)(6.4%);结外边缘区B细胞淋巴瘤(MALT)(5.4%);前体T淋巴细胞白血病/淋巴瘤(T-LBL)(4.5%);以及慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)(3.2%)。平均发病年龄为47.7±16.3(18 - 85岁),男女比例为1.57:1。与中国上海和山西相比,该地区NK/T细胞淋巴瘤的比例更高。与其他国家相比,该地区的FL和CLL/SLL明显较低,而T细胞淋巴瘤的发病率明显高于美国和欧洲。
中国山东地区NHL的临床和病理分布与亚洲人群一致,但与西方国家有显著差异。该地区的NK/T细胞淋巴瘤明显更高。